Northern Clinical Trial Coordinators Oy

The medical center is at the forefront of research in psychiatry, particularly focusing on Major Depressive Disorder (MDD) with moderate-to-severe anhedonia. This condition is characterized by a diminished ability to experience pleasure, which significantly impacts the quality of life.

• Major Depressive Disorder (MDD)
• Anhedonia
• Adjunctive Therapy

Through innovative clinical trials, the center is exploring the efficacy of novel therapeutic agents like aticaprant as adjunctive treatments. This research aims to enhance the effectiveness of existing antidepressant therapies, particularly for patients who have not responded adequately to standard treatments such as SSRIs or SNRIs.